BeOne Medicines (ONC) Return on Invested Capital Growth (3y) (2019 - 2026)

BeOne Medicines (ONC) Return on Invested Capital Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 2.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 3.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00
Dec 31, 2025 1.00
Sep 30, 2025 1.00
Jun 30, 2025 1.00
Mar 31, 2025 1.00
Dec 31, 2024 0.00
Sep 30, 2024 1.00
Jun 30, 2024 1.00
Mar 31, 2024 1.00
Dec 31, 2023 7.00
Sep 30, 2023 33.00
Jun 30, 2023 47.00
Mar 31, 2023 58.00
Dec 31, 2022 41.00
Sep 30, 2022 26.00
Jun 30, 2022 19.00
Mar 31, 2022 20.00
Dec 31, 2021 19.00
Sep 30, 2021 13.00
Jun 30, 2021 7.00